Replies to post #35793 on Intellipharmaceutics International Inc. (IPCI)

[tilator]

the issue with Focalin I thought was PAR had to reduce price to keep business.

Yes I know, but that was not the point in my message. Revenue did increase comparing Q2 to Q1. My point was did growth come evenly during all three months or did something bigger happen towards the end of Q2.

Never mind, but something strange happened today because price did not end up bellow 0.40. I expected it to reach ATL, but it did not.